Welcome to CDC stacks | Use of Spatial Information to Predict Multidrug Resistance in Tuberculosis Patients, Peru - 23911 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Use of Spatial Information to Predict Multidrug Resistance in Tuberculosis Patients, Peru
Filetype[PDF-239.00 KB]


No Related Documents.
You May Also Like:
  1. Coming Soon
    Where is tuberculosis transmission happening? Insights from the literature, new tools to study transmission and implications for the elimination of tuberculosis
    Personal Author:
    AULD, Sara C.; SHAH, N. Sarita; COHEN, Ted; MARTINSON, Neil A.; GANDHI, Neel R.;
    Published:
    Jun 05 2018
    Source:
    Respirology. .
    Description:
    More than 10 million new cases of tuberculosis (TB) are diagnosed worldwide each year. The majority of these cases occur in low- and middle-income countries where the TB epidemic is predominantly driven by transmission. Efforts to 'end TB' will depen...
    Public Access
    Available on:
    December 05, 2019
  2. Multiple Introductions of Multidrug-Resistant Tuberculosis into Households, Lima, Peru
    Personal Author:
    Cohen, Ted; Murray, Megan; Abubakar, Ibrahim; Zhang, Zibiao; Sloutsky, Alexander; Arteaga, Fernando; Chalco, Katiuska; Franke, Molly F.; Becerra, Mercedes C.;
    Published:
    Jun 2011
    Source:
    Emerg Infect Dis. 17(6):969-975.
    Description:
    Two cases of multidrug-resistant tuberculosis (MDR TB) in a household are assumed to reflect within-household transmission. However, in high-incidence areas of MDR TB, secondary cases may arise through exposure to MDR TB in the community. To estimate...
    File Type:
    Filetype[PDF - 189.16 KB]
  3. Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study
    Personal Author:
    Yuen, Courtney M.; Kurbatova, Ekaterina V.; Tupasi, Thelma; Caoili, Janice Campos; Van Der Walt, Martie; Kvasnovsky, Charlotte; Yagui, Martin; Bayona, Jaime; Contreras, Carmen; Leimane, Vaira; Ershova, Julia; Via, Laura E.; Kim, HeeJin; Akksilp, Somsak; Kazennyy, Boris Y.; Volchenkov, Grigory V.; Jou, Ruwen; Kliiman, Kai; Demikhova, Olga V.; Vasilyeva, Irina A.; Dalton, Tracy; Cegielski, J. Peter;
    Published:
    Dec 29 2015
    Source:
    PLoS Med. 12(12).
    Description:
    Background : For treating multidrug-resistant tuberculosis (MDR TB), the World Health Organization (WHO) recommends a regimen of at least four second-line drugs that are likely to be effective as well as pyrazinamide. WHO guidelines indicate only mar...
    File Type:
    Filetype[PDF - 528.88 KB]
  4. National Action Plan for Combating Multidrug-Resistant Tuberculosis : year two report May 2018
    Corporate Author:
    United States. Agency for International Development.. National Institute of Allergy and Infectious Diseases (U.S.). Centers for Disease Control and Prevention (U.S.).
    Published:
    May 2018
    Description:
    NAP-MDR-TB-Year-Two-508.pdf
    File Type:
    Filetype[PDF - 617.78 KB]
  5. Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis
    Personal Author:
    Maryandyshev, Andrey; Pontali, Emanuele; Tiberi, Simon; Akkerman, Onno; Ganatra, Shashank; Sadutshang, Tsetan Dorji; Alffenaar, Jan-Willem; Amale, Rohit; Mullerpattan, Jai; Topgyal, Sonam; Udwadia, Zarir Farokh; Centis, Rosella; D’Ambrosio, Lia; Sotgiu, Giovanni; Migliori, Giovanni Battista;
    Published:
    Oct 17 2017
    Source:
    Emerg Infect Dis. 23(10):1718-1721.
    Description:
    We report the experiences of 5 patients taking bedaquiline with delamanid in combination: 1 patient was cured; 3 culture converted, with 2 continuing and 1 changing therapy; and 1 died from respiratory insufficiency. For 2 patients, QT-interval prolo...
    File Type:
    Filetype[PDF - 997.61 KB]